#stem-cell

UC Davis Health researchers confirmed the safety of the world's first in-utero stem cell therapy for fetal spina bifida in a Phase 1 trial published in The Lancet. All patients showed zero adverse effects and successful outcomes.

UC Davis Health researchers confirmed the safety of the world's first in-utero stem cell therapy for fetal spina bifida in a Phase 1 trial published in The Lancet. All patients showed zero adverse effects and successful outcomes.